| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| The Ramaraju Surgical Cotton Mills Limited |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Non-Current Assets |
|
|
|
Property, Plant & Equipments |
24,803.55 |
27,857.39 |
|
Capital Work-in-Progress |
50.77 |
230.81 |
|
Investment Property |
5.06 |
5.24 |
|
Goodwill |
1,951.50 |
1,951.50 |
|
Intengible assets |
413.51 |
471.97 |
|
Investments in Subsidiary and Associates |
17,306.26 |
19,338.10 |
|
Other Investments |
580.07 |
578.48 |
|
Other Financial Assets |
458.71 |
433.33 |
|
Deferred Tax assets |
2,147.11 |
1116.01 |
|
Other Non-current assets |
65.46 |
38.24 |
|
Current Assets |
|
|
|
Inventories |
13,172.64 |
11,560.21 |
|
Trade Receivables |
8,603.93 |
4,638.23 |
|
Cash And Cash Equivalents |
110.57 |
4,065.74 |
|
Bank balance other than cash and cash equivalents |
6.43 |
5.64 |
|
Other Financial Assets |
569.84 |
341.93 |
|
Current tax assets |
123.94 |
119.28 |
|
Other Current assets |
2,106.19 |
2,538.32 |
|
Total Assets |
72,475.54 |
75,290.42 |
|
Equity |
|
|
|
Equity Share Cpital |
581.5 |
581.5 |
|
Other Equity |
22,733.25 |
25,599.25 |
|
Non-Controlling Interest |
258.34 |
398.53 |
|
Non-Current Liabilities |
|
|
|
Borrowings |
22,185.43 |
23,482.29 |
|
Provisions |
108.42 |
102.49 |
|
Deferred Tax Liabilities (Net) |
18.15 |
9.85 |
|
Other non-current Liabilities |
70.16 |
72.2 |
|
Current Liabilities |
|
|
|
Borrowings |
21,256.66 |
21,561.85 |
|
Total Outstanding dues of micro and small enterprises |
193.78 |
66.47 |
|
Total outstanding dues of creditors other than above |
3,048.94 |
1,196.27 |
|
Other Financial Liabilities |
1,213.86 |
1172.99 |
|
Other Current Liabilities |
380.41 |
655.91 |
|
Provisions |
426.64 |
390.82 |
|
Total Equity and Liabilities |
72,475.54 |
75,290.42 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Revenue from Operations |
|
|
|
Sale of Product |
39,397.11 |
36,064.62 |
|
Other Operating Income |
711.59 |
494.58 |
|
Other Income |
503.38 |
579.18 |
|
Total Income |
40,612.08 |
37,138.38 |
|
Expenses |
|
|
|
Cost of material consumed |
22,053.88 |
20,320.77 |
|
Purchase of stock-in-trade |
4,752.46 |
1,700.77 |
|
Changes in Inventories of Finished goods and Work-in-Progress Stock |
(1,560.48) |
(201.94) |
|
Employee Benefit Expenses |
6,292.99 |
5,594.48 |
|
Power and Fuel |
2,621.18 |
2,747.15 |
|
Finance Cost |
3,858.48 |
3,756.54 |
|
Depreciation and Amortisation Expenses |
2,948.34 |
3,543.14 |
|
Other Expenses |
5,687.39 |
4,703.98 |
|
Total Expenses |
46,654.24 |
42,164.89 |
|
Profit /(Loss) before Exceptional Items and Tax |
(6,042.16) |
(5,026.51) |
|
Exceptional Items |
1,689.70 |
- |
|
Profit Before Tax |
(4,352.46) |
(5,026.51) |
|
Tax Expenses earlier year |
- |
(82.50) |
|
Deferred Tax |
(1,568.40) |
(1,033.86) |
|
Mat Credit (taken)/withdrawn related to earlier year |
545.61 |
414.89 |
|
Profit/(Loss) from Ordinary activities After Tax |
(3,329.67) |
(4,325.04) |
|
Share of Net Profit after tax of of associates accounted for using the equity method |
408.28 |
550.62 |
|
Net Profit for the Period |
(2,921.39) |
(3,774.42) |
|
Shareholders of the Company |
(2,929.58) |
(3,771.14) |
|
Non Controlling Interest |
8.19 |
-3.28 |
|
Other Comprehensive Income/(Loss), net of tax |
-12.22 |
-26.96 |
|
Share of OCI of Associates accounted for using Equity Method |
-15.08 |
100.84 |
|
OCI - Foreign Currency Translation |
82.68 |
-8.68 |
|
Total Comphrensive Income after Tax |
-2,866.01 |
-3,709.22 |
|
Shareholders of the Company |
-2,874.20 |
-3,705.94 |
|
Non Controlling Interest |
8.19 |
-3.28 |
|
Paid Up Equity Share Capital |
581.50 |
581.50 |
|
Other Equity |
22,991.59 |
25,997.78 |
|
Earnings per Equity Share |
|
|
|
Basic |
-50.24 |
-93.86 |
|
Diluted |
-50.24 |
-93.86 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Cash flows from Operating Activities |
|
|
|
Profit before Tax and exceptional items |
(6,042.16) |
(5,026.51) |
|
Adjustments to reconcile profit/(loss): |
|
|
|
Depreciation & Amortisation |
2,948.34 |
3,543.14 |
|
Finance Cost |
3,858.48 |
3,756.54 |
|
Interest Received |
(272.90) |
(238.62) |
|
(Profit) / Loss on Sale of Assets |
63.44 |
(66.04) |
|
Government Grants |
(1.45) |
(1.45) |
|
Operating Profit before Working capital Changes |
553.75 |
1967.06 |
|
Movement in Working Capital: |
|
|
|
Trade Receivables |
(3965.70) |
(826.79) |
|
Inventories |
-1,612.43 |
1,413.11 |
|
Loans and Advances |
236.97 |
2.07 |
|
Trade Payables & Current Liabilities |
1861.90 |
(0.37) |
|
Cash Generated from Operating Activities |
-2925.51 |
2555.08 |
|
Direct Taxes refund received/(Paid) (Net) |
31.62 |
125.38 |
|
Net Cash Generated from Operating Activities |
-2,893.89 |
2680.46 |
|
Cash flows from Investing Activities |
|
|
|
Purchase of Fixed Assets |
(148.81) |
(1,743.52) |
|
Investment in Shares |
- |
(422.43) |
|
Proceeds from Sale of investment in associates |
4029.88 |
- |
|
Proceeds from Sale of assets |
402.34 |
495.85 |
|
Interest Received |
235.73 |
238.62 |
|
Net Cash Generated from Investing Activities |
4,519.14 |
(1,431.48) |
|
Cash Flows from Financing Activities |
|
|
|
Proceeds from right issue , Net of issue expenses |
- |
3655.17 |
|
Proceeds from Long Term Borrowings |
5,600.00 |
6,367.11 |
|
Repayment of Long Term Loan |
(6,896.86) |
(5,121.34) |
|
Proceeds / (Repayment) of Deposits - Related Parties |
903.62 |
- |
|
Proceeds / (Repayment) of Short Term Borrowings (Net) |
(1,208.81) |
1,524.83 |
|
Acquisition Non-Controlling Interest |
(140.19) |
-137.43 |
|
Payment Dividend |
- |
(19.99) |
|
Finance Cost |
(3,837.39) |
(3,756.54) |
|
Net Cash Generated from Financing Activities |
(5,579.63) |
2,511.81 |
|
Net Increase in Cash and Cash Equivalent |
(3,954.38) |
3,760.79 |
|
Opening balance of Cash and Cash Equivalents |
4,071.38 |
310.59 |
|
Closing balance of Cash and Cash Equivalents |
117.00 |
4,071.38 |
|
Cash and Cash Equivalents comprise the following: |
|
|
|
Cash and Cash Equivalents |
110.57 |
4065.74 |
|
Bank Balance Other Than Cash and Cash Equivalents |
6.43 |
5.64 |
|
Total |
117.00 |
4,071.38 |
Here is a summary of the Cash Flow Statement
for the years 2024 and 2025:
Operating
Activities:
In FY 2025, the
company reported a loss before tax and exceptional items of ₹6,042.16 lakhs, a
deeper loss compared to ₹5,026.51 lakhs in FY 2024. After accounting for
non-cash adjustments such as depreciation and amortisation (₹2,948.34 lakhs)
and finance costs (₹3,858.48 lakhs), the operating profit before working
capital changes was ₹553.75 lakhs, down from ₹1,967.06 lakhs in FY 2024.
However, significant cash outflows in working capital—particularly from trade
receivables (₹3,965.70 lakhs) and inventories (₹1,612.43 lakhs)—led to negative
cash generated from operations at ₹2,925.51 lakhs. After considering taxes, the
net
cash used in operating activities stood at ₹2,893.89
lakhs, in stark contrast to the positive
₹2,680.46 lakhs in the previous year.
Investing Activities:
In FY 2025, the
company showed a strong inflow from investing activities amounting to ₹4,519.14
lakhs, primarily driven by the ₹4,029.88 lakhs
from the sale of investments in associates and ₹402.34
lakhs from asset sales. This is a significant turnaround from
FY 2024, where investing activities saw a net outflow of ₹1,431.48
lakhs due to heavy purchases of fixed assets and investments in
shares.
Financing Activities:
The financing cash
flows in FY 2025 turned negative at ₹5,579.63 lakhs, mainly
due to the repayment
of long-term loans (₹6,896.86 lakhs) and high
finance costs (₹3,837.39 lakhs). This contrasts with the
previous year’s positive inflow of ₹2,511.81 lakhs,
which had included proceeds from a right issue and higher borrowings.
Net Cash Flow and Final Balances:
The overall result
was a net
decrease in cash and cash equivalents of ₹3,954.38 lakhs in FY
2025, following a strong increase of ₹3,760.79 lakhs in FY
2024. Consequently, the closing cash balance
as of 31st March 2025 dropped sharply to ₹117 lakhs, down from
₹4,071.38
lakhs the previous year.
